{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/426356403"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "The therapy is intended for patients with relapsing-remitting forms of MS and is currently under review by regulatory authorities in Europe, the US, Australia, Canada and Switzerland." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "zenopa.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/124451442"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/426356403"] } } }
